CLINICAL_TRIALS
withdrawal
· 2021-01-22
Clinical Trial Update: 12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) Subjects [Phase 3]
Summary
A Phase 3 trial evaluating pregabalin for Restless Legs Syndrome was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Restless Legs Syndrome | Phase 3 | Status: WITHDRAWN